These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37175515)

  • 1. APP in the Neuromuscular Junction for the Development of Sarcopenia and Alzheimer's Disease.
    Wu MY; Zou WJ; Lee D; Mei L; Xiong WC
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular Swedish mutant APP-to-Brain axis in the development of Alzheimer's disease.
    Pan JX; Lee D; Sun D; Zhao K; Xiong L; Guo HH; Ren X; Chen P; Lopez de Boer R; Lu Y; Lin H; Mei L; Xiong WC
    Cell Death Dis; 2022 Nov; 13(11):952. PubMed ID: 36357367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP interacts with LRP4 and agrin to coordinate the development of the neuromuscular junction in mice.
    Choi HY; Liu Y; Tennert C; Sugiura Y; Karakatsani A; Kröger S; Johnson EB; Hammer RE; Lin W; Herz J
    Elife; 2013 Aug; 2():e00220. PubMed ID: 23986861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological and functional abnormalities in neuromuscular junctions of Drosophila melanogaster induced by the expression of human APP gene].
    Sarantseva SV; Kislik GA; Tkachenko NA; Vasil'ev AN; Shvartsman AL
    Tsitologiia; 2012; 54(5):421-9. PubMed ID: 22827040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alzheimer's Disease Amyloid Precursor Protein and its Neuritogenic Actions.
    Luu L; Ciccotosto GD; Cappai R
    Curr Alzheimer Res; 2021; 18(10):772-786. PubMed ID: 34879801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer's Disease Pathology Precursors.
    Bonds JA; Shetti A; Bheri A; Chen Z; Disouky A; Tai L; Mao M; Head BP; Bonini MG; Haus JM; Minshall RD; Lazarov O
    J Neurosci; 2019 Oct; 39(43):8576-8583. PubMed ID: 31527120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
    Klevanski M; Herrmann U; Weyer SW; Fol R; Cartier N; Wolfer DP; Caldwell JH; Korte M; Müller UC
    J Neurosci; 2015 Dec; 35(49):16018-33. PubMed ID: 26658856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond pathology: APP, brain development and Alzheimer's disease.
    Soldano A; Hassan BA
    Curr Opin Neurobiol; 2014 Aug; 27():61-7. PubMed ID: 24632309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The upside of APP at synapses.
    Hoe HS; Lee HK; Pak DT
    CNS Neurosci Ther; 2012 Jan; 18(1):47-56. PubMed ID: 21199446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease.
    Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L
    Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP-dependent glial cell line-derived neurotrophic factor gene expression drives neuromuscular junction formation.
    Stanga S; Zanou N; Audouard E; Tasiaux B; Contino S; Vandermeulen G; René F; Loeffler JP; Clotman F; Gailly P; Dewachter I; Octave JN; Kienlen-Campard P
    FASEB J; 2016 May; 30(5):1696-711. PubMed ID: 26718890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pharmacology of amyloid precursor protein.
    Cho Y; Bae HG; Okun E; Arumugam TV; Jo DG
    Pharmacol Ther; 2022 Jul; 235():108122. PubMed ID: 35114285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.